Relaxant effect of atorvastatin on isolated rat gastric fundus strips: implications for Ca2+-signalling mechanisms

被引:3
作者
Kaleli-Durman, Deniz [1 ]
Alp-Yildirim, F. Ilkay [1 ]
Ozdemir, Osman [1 ,2 ]
Uydes-Dogan, B. Sonmez [1 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmacol, TR-34116 Istanbul, Turkey
[2] Cyprus Int Univ, Fac Hlth Sci, Dept Pharmacol, Nicosia, North Cyprus, Cyprus
关键词
atorvastatin; rat gastric fundus; Ca2+ entry; intracellular Ca2+ stores; SERCA; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; SARCOPLASMIC-RETICULUM; K+-CHANNELS; CA2+; SIMVASTATIN; CALCIUM; CONTRACTIONS; PRAVASTATIN; INHIBITION;
D O I
10.1139/cjpp-2018-0723
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Statins are determined to have various pleiotropic effects apart from their lipid-lowering properties. Herein, we investigated the direct effects of atorvastatin on gastric smooth muscle tone. Atorvastatin effectively relaxed isolated rat gastric fundus strips precontracted with acetylcholine, potassium chloride, and serotonin. Incubation of the strips with nitric oxide synthase inhibitor, L-NOARG (10(-4) M, 20 min), L-type voltage-operated Ca2+ channel (VOCC) blocker, nifedipine (10(-6) M, 30 min), K-ATP channel blocker, glibenclamide (10(-5) M, 30 min), or precursor of cholesterol, mevalonate (10(-2) M, 45 min) did not change the relaxations to atorvastatin. However, pretreatment of fundus strips with atorvastatin (3x10(-5)-3x10(-4) M, 30 min) inhibited the contractions to calcium chloride (10(-4)-10(-1) M), acetylcholine (10(-4) M), and caffeine (20 mM) in the calcium-free medium. Moreover, atorvastatin reduced the contractions induced by sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, cyclopiazonic acid (10(-7)-3x10(-5) M). The current study demonstrated that atorvastatin produces an acute relaxant effect on gastric fundus strips, which appears to be mediated by several Ca2+-signalling mechanisms such as the blockade of L-type VOCC-independent Ca2+ entry, decrease in smooth muscle Ca2+ sensitivity, inhibition of IP3- and ryanodine-sensitive intracellular stores to mediate Ca2+ release, as well as the activation of SERCA. This acute relaxing effect seems unlikely to be related with nitric oxide, K-ATP channels, and the mevalonate pathway.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 46 条
[1]   Current statins show calcium channel blocking activity through voltage gated channels [J].
Ali, Niaz ;
Begum, Robina ;
Faisal, Muhammad Saleh ;
Khan, Aslam ;
Nabi, Muhammad ;
Shehzadi, Gulfam ;
Ullah, Shakir ;
Ali, Waqar .
BMC PHARMACOLOGY & TOXICOLOGY, 2016, 17
[2]   Lovastatin induces relaxation and inhibits L-type Ca2+ current in the rat basilar artery [J].
Bergdahl, A ;
Persson, E ;
Hellstrand, P ;
Swärd, K .
PHARMACOLOGY & TOXICOLOGY, 2003, 93 (03) :128-134
[3]  
BOECKXSTAENS GE, 1991, J PHARMACOL EXP THER, V256, P441
[4]   CHOLINERGIC MECHANISMS IN SMOOTH-MUSCLE [J].
BOLTON, TB .
BRITISH MEDICAL BULLETIN, 1979, 35 (03) :275-283
[5]   Cardiovascular effects of lovastatin in normotensive and spontaneously hypertensive rats [J].
Bravo, L ;
Herrera, MD ;
Marhuenda, E ;
Perez-Guerrero, C .
GENERAL PHARMACOLOGY, 1998, 30 (03) :331-336
[6]   The reactivity of serotonin, acetylcholine and KCl-induced contractions to relaxant agents in the rat gastric fundus [J].
Buharalioglu, CK ;
Akar, F .
PHARMACOLOGICAL RESEARCH, 2002, 45 (04) :325-331
[7]   CALCIUM-CHANNEL BLOCKING-AGENTS FOR GASTROINTESTINAL DISORDERS [J].
CASTELL, DO .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (03) :B210-B213
[8]   RELATIONSHIP BETWEEN MEVALONATE PATHWAY AND ARTERIAL MYOCYTE PROLIFERATION - IN-VITRO STUDIES WITH INHIBITORS OF HMG-COA REDUCTASE [J].
CORSINI, A ;
MAZZOTTI, M ;
RAITERI, M ;
SOMA, MR ;
GABBIANI, G ;
FUMAGALLI, R ;
PAOLETTI, R .
ATHEROSCLEROSIS, 1993, 101 (01) :117-125
[9]   Comparative effects of K+ channel modulating agents on contractions of rat intestinal smooth muscle [J].
Davies, MP ;
McCurrie, JR ;
Wood, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 297 (03) :249-256
[10]   Effect of simvastatin on vascular smooth muscle responsiveness:: involvement of Ca2+ homeostasis [J].
de Sotomayor, MA ;
Pérez-Guerrero, C ;
Herrera, MD ;
Marhuenda, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 415 (2-3) :217-224